Sirona Biochem Corp.
SRBCF
$0.01
$0.00-10.44%
OTC PK
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -64.06% | 45.39% | -17.41% | -70.04% | -33.02% |
| Total Depreciation and Amortization | -70.31% | 164.29% | 0.00% | 18.75% | 255.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.51% | -302.69% | 1,324.03% | -86.37% | 48.08% |
| Change in Net Operating Assets | 92.92% | -60.52% | -145.63% | 324.56% | -265.05% |
| Cash from Operations | 0.17% | 9.68% | -150.34% | 36.45% | -96.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 919.66% | -72.50% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 64.54% | -- |
| Issuance of Common Stock | -- | 623.67% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,016.70% | -60.48% | 223.23% | 375.87% | -211.59% |
| Foreign Exchange rate Adjustments | 475.00% | -92.31% | -107.02% | 171.25% | 80.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.91% | -111.10% | -65.31% | 136.53% | -166.94% |